Blood-based gene detection of non-small cell lung cancer
OwnerAndrea HOFMANN, Joachim L. Schultze +3inventors
InventorsAndrea HOFMANN, Joachim L. Schultze, Andrea Staratschek-Jox, Jurgen Wolf, Thomas Zander
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for early detection of non-small cell lung cancer based on the abundance of RNAs from blood samples as well as diagnostic tools such as kits and arrays suitable for such method.
Claims15
A method for the detection of non-small cell lung cancer (NSCLC) in a human individual based on RNA obtained from a blood sample obtained from the individual, comprising:
- determining the abundance of at least 5 RNAs in the sample that are chosen from the RNAs listed in Table 2, and
- concluding based on the measured abundance whether the patient has NSCLC.
A microarray for the detection of NSCLC comprising probes for detecting at least 5, or at least 7, or at least 11 RNAs that are chosen from the RNAs listed in Table 2.
A kit for the detection of NSCLC, comprising means for determining the abundance of at least 5 RNAs in the sample that are chosen from the RNAs listed in Table 2.
Dependencies are inferred from the claim text.